Abstract:Forkhead box O1 (FoxO1) is a transcription factor that mediates the inhibitory effect of insulin on target genes in hepatic metabolism. Hepatic FoxO1 activity is up-regulated to promote glucose production during fasting and is suppressed to limit postprandial glucose excursion after meals. Increased FoxO1 activity augments the expression of insulin receptor (IR) and IR substrate (IRS)2, which in turn inhibits FoxO1 activity in response to reduced insulin action. To address the underlying physiology of such a feedback loop for regulating FoxO1 activity, we delivered FoxO1-ADA by adenovirus-mediated gene transfer into livers of adult mice. FoxO1-ADA is a constitutively active allele that is refractory to insulin inhibition, allowing us to determine the metabolic effect of a dislodged FoxO1 feedback loop in mice. We show that hepatic FoxO1-ADA production resulted in significant induction of IR and IRS2 expression. Mice with increased FoxO1-ADA production exhibited near glycogen depletion. Unexpectedly, hepatic FoxO1-ADA production elicited a profound unfolded protein response, culminating in the induction of hepatic glucose-regulated protein 78 (GRP78) expression. These findings were recapitulated in primary human and mouse hepatocytes. FoxO1 targeted GRP78 gene for trans-activation via selective binding to an insulin responsive element in the GRP78 promoter. This effect was counteracted by insulin. Our studies underscore the importance of an IR and IRS2-dependent feedback loop to keep FoxO1 activity in check for maintaining hepatic glycogen homeostasis and promoting adaptive unfolded protein response in response to altered metabolism and insulin action. Excessive FoxO1 activity, resulting from a dislodged FoxO1 feedback loop in insulin resistant liver, is attributable to hepatic endoplasmic reticulum stress and metabolic abnormalities in diabetes.

FoxO1 as a tissue-specific therapeutic target for type 2 diabetes

The role of FoxO1 and its modulation with small molecules in the development of diabetes mellitus: A review

Targeting FoxO1 for hypertriglyceridemia.

Role of FoxO1 in regulating autophagy in type 2 diabetes mellitus (Review)

FoxO1 Links Hepatic Insulin Action to Endoplasmic Reticulum Stress

Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1

Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone

FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes

The role of FOXO1 in β-cell failure and type 2 diabetes mellitus

Aberrant Forkhead Box O1 Function is Associated with Impaired Hepatic Metabolism

FoxO1 Plays an Important Role in Regulating Β-Cell Compensation for Insulin Resistance in Male Mice.

Metabolic aspects of cardiovascular diseases: Is FoxO1 a player or a target?

Nuclear Transcription Factor Foxo1 and Glucose,lipid Metabolism

Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy

FOXO1 inhibition potentiates endothelial angiogenic functions in diabetes via suppression of mitochondrial fission

FoxO integration of insulin signaling with glucose and lipid metabolism.

Inhibitory regulation of FoxO1 in PPARδ expression drives mitochondria dysfunction and insulin resistance

Regulation of FoxOs Transcription Factors on Body Metabolism

FOXOs in the Impaired Heart: New Therapeutic Targets for Cardiac Diseases.

Therapeutic strategies targeting FOXO transcription factors

Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure